Bio Protocol vs USD.AI — how do they compare? Bio Protocol trades at Rp443.9 (market cap Rp1T, Rp172,7M 24h volume), while USD.AI trades at Rp405.16 (market cap Rp810,18M, Rp148,5M 24h volume). The key difference: Bio Protocol is far larger — about 1234.3× USD.AI's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 2B / 10B CHIP (20%) for USD.AI. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and USD.AI for 4 Days on average.
| BIO | CHIP | |
|---|---|---|
Market Cap | Rp1T | Rp810,18M |
Volume (24h) | Rp172,7M | Rp148,5M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2B / 10B CHIP (20%) |
Typical Hold Time | 17 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
USD.AI is currently trading at Rp414 with a bearish technical outlook, showing oversold conditions on short-term RSI but strong selling pressure from moving averages. The token trades near its R1 resistance at Rp412 with support at Rp387. With only 20% of the 10M max supply in circulation and low 4-day average hold time, the project shows early-stage tokenomics with limited network adoption metrics available.
Overall outlook remains cautious due to bearish technical signals and limited fundamental developments. Key opportunities include potential oversold bounce from RSI levels, while major risks involve low liquidity (Rp831M market cap), high volatility, and lack of recent ecosystem updates that could impact token utility and adoption trajectory.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →CHIP is the native asset of USD.AI, a protocol that connects blockchain-based finance with AI computing infrastructure. The ecosystem facilitates funding for GPU resources used in AI workloads and links digital assets with real-world compute operations through tokenized infrastructure and on-chain financial mechanisms.
Read more on CHIP →